glp-1 news september 26 2025 GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo What's next for GLP-1 innovation:

EAT, Epicardial adipose tissue

In some studies, these medications enabled: Faster achievement of technical operability Easier laparoscopic access Improved metabolic control Higher diabetes remission rates, especially in insulin-dependent patients 2

The demand for semaglutide and tirzepatide was so high that the FDA declared a shortage of them, which made it legal for generic drug companies and compounding pharmacies to prepare and distribute these drugs

PlexusDx compounded semaglutide injection starts at $149 per montha fraction of brand costswith flat monthly pricing regardless of dose level

We guide our patients through the process, starting with a lower dose to minimize side effects and gradually increasing it to optimize results

With careful patient selection and thoughtful integration, GLP1s can be a valuable addition to comprehensive PCOS care